Chiral Quest (Suzhou) Co., Ltd.
PrivateLast Round
Series C
Aug 8, 2013
Total Funding Raised
$41M
Company Overview
Chiral Quest (Suzhou) Co., Ltd. is a pharmaceutical CDMO company that specializes in the development and production of chiral compounds, pharmaceutical intermediates, and fine chemicals using asymmetric hydrogenation and biocatalysis technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chiral Quest (Suzhou) Co., Ltd. Comparables
Compare Chiral Quest (Suzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou Lead Biotech Co., Ltd. | 70% |
For institutional investors. Book with your work email.
Chiral Quest (Suzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 8, 2013 | ||||
| Series B | Nov 18, 2008 | ||||
| Series A | Jul 1, 2007 |
For institutional investors. Book with your work email.
Chiral Quest (Suzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series C, Series A |
| KPCB China | Series C, Series B |
| Japan Asia Investment Co., Ltd. | Series B |
| China Renaissance Capital Investment | Series B |
| Infinity Group | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2024
Grew 21% QoQ, from 14 to 17 employees.
- Oct 20, 2024
Grew 21% QoQ from 14 to 17 employees.
For institutional investors. Book with your work email.
Chiral Quest (Suzhou) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Chiral Quest (Suzhou) Co., Ltd.'s valuation, stock price, and market status.
Is Chiral Quest (Suzhou) Co., Ltd. a public or private company?
Chiral Quest (Suzhou) Co., Ltd. is a private company.
What is the current stock price of Chiral Quest (Suzhou) Co., Ltd.?
Chiral Quest (Suzhou) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Chiral Quest (Suzhou) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Chiral Quest (Suzhou) Co., Ltd. worth (valuation)?
Valuation information for Chiral Quest (Suzhou) Co., Ltd. is not publicly available.
Can I buy Chiral Quest (Suzhou) Co., Ltd. stock?
Chiral Quest (Suzhou) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Chiral Quest (Suzhou) Co., Ltd.'s last funding round?
Chiral Quest (Suzhou) Co., Ltd.'s most recent funding round was Series C on August 8, 2013.
Who are the main investors in Chiral Quest (Suzhou) Co., Ltd.?
Key investors in Chiral Quest (Suzhou) Co., Ltd. include Oriza Holdings, KPCB China, Japan Asia Investment Co., Ltd., China Renaissance Capital Investment, Infinity Group.
Will Chiral Quest (Suzhou) Co., Ltd. IPO soon?
No public IPO plans have been announced for Chiral Quest (Suzhou) Co., Ltd..
How can I track Chiral Quest (Suzhou) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Chiral Quest (Suzhou) Co., Ltd.'s shares on secondary markets.